INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 120 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.62 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $23,000 | +64.3% | 7,082 | +2.9% | 0.00% | – |
Q3 2019 | $14,000 | -33.3% | 6,882 | 0.0% | 0.00% | – |
Q2 2019 | $21,000 | -16.0% | 6,882 | 0.0% | 0.00% | – |
Q1 2019 | $25,000 | -21.9% | 6,882 | -6.5% | 0.00% | – |
Q4 2018 | $32,000 | -33.3% | 7,357 | -14.5% | 0.00% | – |
Q3 2018 | $48,000 | -79.7% | 8,607 | -82.9% | 0.00% | -100.0% |
Q2 2018 | $237,000 | 0.0% | 50,457 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $237,000 | +13.9% | 50,457 | +0.3% | 0.00% | 0.0% |
Q4 2017 | $208,000 | -36.4% | 50,320 | -2.4% | 0.00% | -50.0% |
Q3 2017 | $327,000 | -15.9% | 51,561 | +3.8% | 0.00% | -20.0% |
Q2 2017 | $389,000 | +23.9% | 49,674 | +4.9% | 0.01% | +25.0% |
Q1 2017 | $314,000 | +423.3% | 47,349 | +521.6% | 0.00% | +300.0% |
Q4 2016 | $60,000 | -10.4% | 7,617 | +7.4% | 0.00% | 0.0% |
Q3 2016 | $67,000 | +11.7% | 7,092 | +8.3% | 0.00% | 0.0% |
Q2 2016 | $60,000 | +3.4% | 6,548 | -3.0% | 0.00% | 0.0% |
Q1 2016 | $58,000 | +81.2% | 6,748 | +44.3% | 0.00% | 0.0% |
Q4 2015 | $32,000 | +39.1% | 4,675 | +19.1% | 0.00% | – |
Q3 2015 | $23,000 | -23.3% | 3,925 | +5.4% | 0.00% | -100.0% |
Q2 2015 | $30,000 | +114.3% | 3,725 | +115.9% | 0.00% | – |
Q1 2015 | $14,000 | +7.7% | 1,725 | +21.1% | 0.00% | – |
Q4 2014 | $13,000 | -7.1% | 1,425 | 0.0% | 0.00% | – |
Q3 2014 | $14,000 | -26.3% | 1,425 | -20.8% | 0.00% | -100.0% |
Q2 2014 | $19,000 | – | 1,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|